Effect of variations in atelectasis on tumor displacement during radiation therapy for locally advanced lung cancer

by Nathan Tennyson, MD, Elisabeth Weiss, MD, William Sleeman, MS, Mihaela Rosu, PhD, Nuzhat Jan, MD, Geoffrey D. Hugo, PhD
Published 2017-01-01

Evaluating the potential benefit of reduced planning target volume margins for low and intermediate risk patients with prostate cancer using real-time electromagnetic tracking

by Avinash R. Chaurasia, MD, Kelly J. Sun, MS, Christopher Premo, MD, Timothy Brand, MD, Brent Tinnel, MD, Stacie Barczak, RN, John Halligan, MD, Michael Brown, MD, Dusten Macdonald, MD
Published 2018-10-01

Toxicity of radiation and immunotherapy combinations

by Vivek Verma, MD, Taylor R. Cushman, BS, Chad Tang, MD, James W. Welsh, MD
Published 2018-10-01

Fractionated stereotactic radiation therapy for intact brain metastases

by Samuel R. Marcrom, MD, Andrew M. McDonald, MD, Jonathan W. Thompson, MD, Richard A. Popple, PhD, Kristen O. Riley, MD, James M. Markert, MD, Christopher D. Willey, MD, PhD, Markus Bredel, MD, PhD, John B. Fiveash, MD
Published 2017-10-01

Cardiac-sparing radiation therapy using positioning breast shell for patients with left-sided breast cancer who are ineligible for breath-hold techniques

by Kurian Joseph, MD, FRCPC, Heather Warkentin, MSc, Sunita Ghosh, PhD, Lee-Anne Polkosnik, CMD, Kent Powell, CMD, Matthew Brennan, HNC, Brad Warkentin, PhD, Johanna Jacobs, Khalifa Alkaabi, MBBS, Susan Chafe, MD, FRCPC, Keith Tankel, MD, FRCPC, Zsolt Gabos, MD, FRCPC, Hong-Wei Liu, MD, FRCPC, Patricia Tai, MD, FRCPC
Published 2017-10-01

Hippocampal dose volume histogram predicts Hopkins Verbal Learning Test scores after brain irradiation

by Catherine Okoukoni, PhD, Emory R. McTyre, MD, Diandra N. Ayala Peacock, MD, Ann M. Peiffer, PhD, Roy Strowd, MD, Christina Cramer, MD, William H. Hinson, PhD, Steve Rapp, PhD, Linda Metheny-Barlow, PhD, Edward G. Shaw, MD, MA, Michael D. Chan, MD
Published 2017-10-01

ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II

by Nicholas G. Zaorsky, MD, Timothy N. Showalter, MD MPH, Gary A. Ezzell, PhD, Paul L. Nguyen, MD, Dean G. Assimos, MD, Anthony V. D'Amico, MD PhD, Alexander R. Gottschalk, MD PhD, Gary S. Gustafson, MD, Sameer R. Keole, MD, Stanley L. Liauw, MD, Shane Lloyd, MD, Patrick W. McLaughlin, MD, Benjamin Movsas, MD, Bradley R. Prestidge, MD MS, Al V. Taira, MD, Neha Vapiwala, MD, Brian J. Davis, MD PhD
Published 2017-01-01

A method to improve dose uniformity during total skin electron beam therapy in patients with pendulous breasts

by Brian J. King, MD, Christopher L. Deufel, PhD, Sarah E. Locher, PhD, Luke B. McLemore, MS, Barbara S. Brekke-Hackman, RTT, James A. Martenson, MD
Published 2017-07-01

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial

by Susanne M. Arnold, MD, Mahesh Kudrimoti, MD, Emily V. Dressler, PhD, John F. Gleason Jr., MD, Natalie L. Silver, MD, William F. Regine, MD, Joseph Valentino, MD
Published 2016-10-01

Urinary quality of life outcomes in men who were treated with image-guided intensity-modulated radiation therapy for prostate cancer

by Simpa S. Salami, MD MPH, Edward Obedian, MD, Shawn Zimberg, MD, Carl A. Olsson, MD
Published 2016-10-01

Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529

by Devarati Mitra, MD, PhD, Theodore S. Hong, MD, Nora Horick, MS, Brent Rose, MD, Lorraine N. Drapek, NP, Lawrence S. Blaszkowsky, MD, Jill N. Allen, MD, Eunice L. Kwak, MD, PhD, Janet E. Murphy, MD, Jeffrey W. Clark, MD, David P. Ryan, MD, James C. Cusack, MD, Liliana G. Bordeianou, MD, David L. Berger, MD, Jennifer Y. Wo, MD
Published 2017-04-01

Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system

by Benjamin W. Fischer-Valuck, MD, Lauren Henke, MD, Olga Green, PhD, Rojano Kashani, PhD, Sahaja Acharya, MD, Jeffrey D. Bradley, MD, Clifford G. Robinson, MD, Maria Thomas, MD, PhD, Imran Zoberi, MD, Wade Thorstad, MD, Hiram Gay, MD, Jiayi Huang, MD, Michael Roach, MD, Vivian Rodriguez, PhD, Lakshmi Santanam, PhD, Harold Li, PhD, Hua Li, PhD, Jessika Contreras, MD, Thomas Mazur, PhD, Dennis Hallahan, MD, Jeffrey R. Olsen, MD, Parag Parikh, MD, Sasa Mutic, PhD, Jeff Michalski, MD, MBA
Published 2017-07-01

The big data effort in radiation oncology: Data mining or data farming?

by Charles S. Mayo, PhD, Marc L. Kessler, PhD, Avraham Eisbruch, MD, Grant Weyburne, BS, Mary Feng, MD, James A. Hayman, MD, Shruti Jolly, MD, Issam El Naqa, PhD, Jean M. Moran, PhD, Martha M. Matuszak, PhD, Carlos J. Anderson, PhD, Lynn P. Holevinski, BS, Daniel L. McShan, PhD, Sue M. Merkel, MSA RT(R)(T), Sherry L. Machnak, MBA RT(T), Theodore S. Lawrence, MD PhD, Randall K. Ten Haken, PhD
Published 2016-10-01

Obsessive-compulsive disorder after therapy for an optic pathway glioma

by Diana Guzman, MA, Eeva Edds, MA, Soumen Khatua, MD, Susan L. McGovern, MD, PhD, Rhonda Robert, PhD
Published 2018-01-01

Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy

by Hanne A. Eide, MD, Ingerid Skjei Knudtsen, MSc, Vandana Sandhu, PhD, Ayca M. Løndalen, MD, Ann Rita Halvorsen, MSc, Azadeh Abravan, MSc, Elin H. Kure, PhD, Trond V. Bogsrud, MD, PhD, Odd Terje Brustugun, MD, PhD, Jon Amund Kyte, MD, PhD, Eirik Malinen, PhD, Åslaug Helland, MD, PhD
Published 2018-04-01

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions

by Chelsea C. Pinnix, MD, PhD, Therese Y. Andraos, MD, Bouthaina Dabaja, MD, Sarah Milgrom, MD, Grace Smith, MD, PhD, Dai Chihara, MD, PhD, Andrea Ng, MD, Luis E. Fayad, MD, Yasuhiro Oki, MD, Sattva Neelapu, MD, Jason Westin, MD, M. Alma Rodriguez, MD, Loretta J. Nastoupil, MD
Published 2017-07-01

Premature discontinuation of curative radiation therapy: Insights from head and neck irradiation

by Stanislav Lazarev, MD, Vishal Gupta, MD, Zahra Ghiassi-Nejad, MD, PhD, Brett Miles, DDS, MD, FACS, Bethann Scarborough, MD, Krzysztof J. Misiukiewicz, MD, Batya Reckson, LCSW-R, OSW-C, Ren-Dih Sheu, PhD, Richard L. Bakst, MD
Published 2018-01-01

Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by risk category in an academic safety net hospital

by Carolyn K. Kan, MPH, Muhammad M. Qureshi, MBBS, MPH, Apar Gupta, MD, Ankit Agarwal, MD, MBA, Gretchen A. Gignac, MD, B. Nicolas Bloch, MD, Nicholas Thoreson, BS, Ariel E. Hirsch, MD
Published 2018-04-01

Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostat...

by Carlos E. Vargas, MD, Matthew Q. Schmidt, MD, Joshua R. Niska, MD, William F. Hartsell, MD, Sameer R. Keole, MD, Lucius Doh, MD, John Han-Chih Chang, MD, Christopher Sinesi, MD, Rossio Rodriquez, CTR, Mark Pankuch, PhD, Gary L. Larson, MD
Published 2018-07-01

Late toxicity after post-prostatectomy intensity modulated radiation therapy: Evaluating normal-tissue sparing guidelines

by Adil S. Akthar, MD, Anthony C. Wong, MD, PhD, Akash D. Parekh, MD, Greg Hubert, BS, RT(T), CMD, Christina H. Son, MD, Charles A. Pelizzari, PhD, Stanley L. Liauw, MD
Published 2018-07-01